Halma (LSE:HLMA) has raised its adjusted EBIT margin guidance following first-half trading, while forecasting low double-digit organic revenue growth for the full year.
The FTSE 100 technology group said growth was broad-based across its operations despite economic and geopolitical uncertainty. Halma also reported continued order intake and cash generation during the period.
Adjusted EBIT Margin Guidance Raised
Halma now expects an adjusted EBIT margin of between 23.5% and 24% for the 2027 financial year, compared with previous guidance of approximately 22.7%.
The company expects low double-digit organic revenue growth for the full year.
This includes an approximately five percentage point contribution from its photonics business, where Halma expects organic revenue growth of around 30%.
Halma also said a stronger pound is expected to have a modest negative effect on reported revenue and profit through currency translation.
Acquisition Spending Reaches £515 Million
Halma reported record acquisition spending of £515 million across six transactions as it continued to deploy capital into its portfolio.
The group also completed three disposals, generating approximately £83 million.
Halma operates a decentralised business model, with its individual companies retaining operational autonomy while capital allocation and portfolio decisions are managed at group level.
Halma Operates Across Three Market Sectors
Halma comprises technology businesses operating across safety, environmental and analysis, and healthcare markets.
Its businesses develop products and technologies used in areas including safety and critical infrastructure, environmental monitoring and analysis, and the prevention, diagnosis and treatment of medical conditions.
The group employs more than 9,000 people across more than 20 countries.
Leave a Reply